Reynders McVeigh Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,384
Closed -$435K 240
2019
Q3
$435K Hold
4,384
0.05% 145
2019
Q2
$405K Buy
4,384
+172
+4% +$16.3K 0.04% 150
2019
Q1
$397K Sell
4,212
-489
-10% -$42.8K 0.04% 149
2018
Q4
$301K Sell
4,701
-39,189
-89% -$2.89M 0.04% 171
2018
Q3
$3.93M Buy
43,890
+1,659
+4% +$147K 0.46% 44
2018
Q2
$3.35M Buy
42,231
+8,833
+26% +$733K 0.43% 47
2018
Q1
$2.98M Buy
33,398
+1,009
+3% +$96.9K 0.38% 49
2017
Q4
$3.38M Buy
32,389
+10,485
+48% +$1.18M 0.44% 47
2017
Q3
$3.19M Buy
21,904
+16,592
+312% +$2.26M 0.42% 47
2017
Q2
$690K Sell
5,312
-275
-5% -$33.7K 0.09% 116
2017
Q1
$695K Sell
5,587
-750
-12% -$89.8K 0.1% 118
2016
Q4
$734K Buy
6,337
+72
+1% +$8.02K 0.1% 116
2016
Q3
$655K Buy
6,265
+24
+0.4% +$2.6K 0.1% 121
2016
Q2
$616K Sell
6,241
-331
-5% -$34.2K 0.09% 128
2016
Q1
$658K Sell
6,572
-110
-2% -$11.3K 0.1% 119
2015
Q4
$800K Buy
6,682
+390
+6% +$45.1K 0.13% 95
2015
Q3
$681K Buy
6,292
+130
+2% +$16.1K 0.12% 106
2015
Q2
$713K Buy
6,162
+3,050
+98% +$349K 0.12% 104
2015
Q1
$359K Buy
+3,112
New +$372K 0.06% 143

Other funds holding CELG

Reynders McVeigh Capital Management's CELG Position: Q4 2019 in Review

Reynders McVeigh Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,384 shares — an estimated $435K sold.

Reynders McVeigh Capital Management first reported a position in CELG in Q1 2015 and held it in 19 quarters. The position peaked at $3.93M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Reynders McVeigh Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 4,384 Celgene Corp shares in Q4 2019, an estimated $435K.
  • Reynders McVeigh Capital Management first reported a position in Celgene Corp in Q1 2015 and held it in 19 quarters.
  • Reynders McVeigh Capital Management's Celgene Corp position peaked at $3.93M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.